Protocol to Obtain Blood Samples for Leukemia Research
Completed
Conditions studied: Chronic Lymphocytic Leukemia
In brief
The purpose of this study is to collect a blood sample in patients with Chronic Lymphocytic Leukemia (CLL).
Key facts
- Study ID
- NCT00889031
- Run by
- Dartmouth-Hitchcock Medical Center
- People needed
- 187
- Starts
- 2009-04-01
- Expected to finish
- 2018-03-09
- Last updated by the study team
- 2020-04-07
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients undergoing routine blood draws as part of their ongoing follow-up for Chronic Lymphocytic Leukemia (CLL) at the Norris Cotton Cancer Center of DHMC.
You may not qualify if…
- Patients who have received cytotoxic drug, oral or intravenous steroid or targeted antibody therapy for CLL or other disease process within the past 6 months are excluded. Use of intravenous immunoglobulin (IVIg) is not a reason for exclusion.
Where it is running
- Dartmouth-Hitchcock Medical Center — Lebanon, New Hampshire, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.